386 related articles for article (PubMed ID: 19414740)
1. Cutting edge: IL-23 receptor gfp reporter mice reveal distinct populations of IL-17-producing cells.
Awasthi A; Riol-Blanco L; Jäger A; Korn T; Pot C; Galileos G; Bettelli E; Kuchroo VK; Oukka M
J Immunol; 2009 May; 182(10):5904-8. PubMed ID: 19414740
[TBL] [Abstract][Full Text] [Related]
2. Interleukin-1 and IL-23 induce innate IL-17 production from gammadelta T cells, amplifying Th17 responses and autoimmunity.
Sutton CE; Lalor SJ; Sweeney CM; Brereton CF; Lavelle EC; Mills KH
Immunity; 2009 Aug; 31(2):331-41. PubMed ID: 19682929
[TBL] [Abstract][Full Text] [Related]
3. IL-7/IL-7 Receptor Signaling Differentially Affects Effector CD4+ T Cell Subsets Involved in Experimental Autoimmune Encephalomyelitis.
Arbelaez CA; Glatigny S; Duhen R; Eberl G; Oukka M; Bettelli E
J Immunol; 2015 Sep; 195(5):1974-83. PubMed ID: 26223651
[TBL] [Abstract][Full Text] [Related]
4. IL-23-driven encephalo-tropism and Th17 polarization during CNS-inflammation in vivo.
Gyülvészi G; Haak S; Becher B
Eur J Immunol; 2009 Jul; 39(7):1864-9. PubMed ID: 19544494
[TBL] [Abstract][Full Text] [Related]
5. Liver X receptor agonist regulation of Th17 lymphocyte function in autoimmunity.
Xu J; Wagoner G; Douglas JC; Drew PD
J Leukoc Biol; 2009 Aug; 86(2):401-9. PubMed ID: 19406833
[TBL] [Abstract][Full Text] [Related]
6. The dichotomous pattern of IL-12r and IL-23R expression elucidates the role of IL-12 and IL-23 in inflammation.
Chognard G; Bellemare L; Pelletier AN; Dominguez-Punaro MC; Beauchamp C; Guyon MJ; Charron G; Morin N; Sivanesan D; Kuchroo V; Xavier R; Michnick SW; Chemtob S; Rioux JD; Lesage S
PLoS One; 2014; 9(2):e89092. PubMed ID: 24586521
[TBL] [Abstract][Full Text] [Related]
7. A Th17-like developmental process leads to CD8(+) Tc17 cells with reduced cytotoxic activity.
Huber M; Heink S; Grothe H; Guralnik A; Reinhard K; Elflein K; Hünig T; Mittrücker HW; Brüstle A; Kamradt T; Lohoff M
Eur J Immunol; 2009 Jul; 39(7):1716-25. PubMed ID: 19544308
[TBL] [Abstract][Full Text] [Related]
8. Encephalitogenic T cells that stably express both T-bet and ROR gamma t consistently produce IFNgamma but have a spectrum of IL-17 profiles.
Abromson-Leeman S; Bronson RT; Dorf ME
J Neuroimmunol; 2009 Oct; 215(1-2):10-24. PubMed ID: 19692128
[TBL] [Abstract][Full Text] [Related]
9. Suppression of human and mouse Th17 differentiation and autoimmunity by an endogenous Interleukin 23 receptor cytokine-binding homology region.
Guo W; Luo C; Wang C; Wang YH; Wang X; Gao XD; Yao WB
Int J Biochem Cell Biol; 2014 Oct; 55():304-10. PubMed ID: 25263529
[TBL] [Abstract][Full Text] [Related]
10. Getting to the crux of the matter: IL-23 and Th17 cell accumulation in the CNS.
Segal BM
Eur J Immunol; 2009 Jul; 39(7):1713-5. PubMed ID: 19582738
[TBL] [Abstract][Full Text] [Related]
11. Cutting edge: NKT cells constitutively express IL-23 receptor and RORgammat and rapidly produce IL-17 upon receptor ligation in an IL-6-independent fashion.
Rachitskaya AV; Hansen AM; Horai R; Li Z; Villasmil R; Luger D; Nussenblatt RB; Caspi RR
J Immunol; 2008 Apr; 180(8):5167-71. PubMed ID: 18390697
[TBL] [Abstract][Full Text] [Related]
12. The receptor SIGIRR suppresses Th17 cell proliferation via inhibition of the interleukin-1 receptor pathway and mTOR kinase activation.
Gulen MF; Kang Z; Bulek K; Youzhong W; Kim TW; Chen Y; Altuntas CZ; Sass Bak-Jensen K; McGeachy MJ; Do JS; Xiao H; Delgoffe GM; Min B; Powell JD; Tuohy VK; Cua DJ; Li X
Immunity; 2010 Jan; 32(1):54-66. PubMed ID: 20060329
[TBL] [Abstract][Full Text] [Related]
13. CD4
Razawy W; Asmawidjaja PS; Mus AM; Salioska N; Davelaar N; Kops N; Oukka M; Alves CH; Lubberts E
Eur J Immunol; 2020 Feb; 50(2):245-255. PubMed ID: 31778214
[TBL] [Abstract][Full Text] [Related]
14. The protein tyrosine kinase Tec regulates a CD44highCD62L- Th17 subset.
Boucheron N; Sharif O; Schebesta A; Croxford A; Raberger J; Schmidt U; Vigl B; Bauer J; Bankoti R; Lassmann H; Epstein MM; Knapp S; Waisman A; Ellmeier W
J Immunol; 2010 Nov; 185(9):5111-9. PubMed ID: 20870948
[TBL] [Abstract][Full Text] [Related]
15. The interleukin 23 receptor is essential for the terminal differentiation of interleukin 17-producing effector T helper cells in vivo.
McGeachy MJ; Chen Y; Tato CM; Laurence A; Joyce-Shaikh B; Blumenschein WM; McClanahan TK; O'Shea JJ; Cua DJ
Nat Immunol; 2009 Mar; 10(3):314-24. PubMed ID: 19182808
[TBL] [Abstract][Full Text] [Related]
16. Retinoic acid increases Foxp3+ regulatory T cells and inhibits development of Th17 cells by enhancing TGF-beta-driven Smad3 signaling and inhibiting IL-6 and IL-23 receptor expression.
Xiao S; Jin H; Korn T; Liu SM; Oukka M; Lim B; Kuchroo VK
J Immunol; 2008 Aug; 181(4):2277-84. PubMed ID: 18684916
[TBL] [Abstract][Full Text] [Related]
17. T-bet regulates the fate of Th1 and Th17 lymphocytes in autoimmunity.
Gocke AR; Cravens PD; Ben LH; Hussain RZ; Northrop SC; Racke MK; Lovett-Racke AE
J Immunol; 2007 Feb; 178(3):1341-8. PubMed ID: 17237380
[TBL] [Abstract][Full Text] [Related]
18. RBPJ Controls Development of Pathogenic Th17 Cells by Regulating IL-23 Receptor Expression.
Meyer Zu Horste G; Wu C; Wang C; Cong L; Pawlak M; Lee Y; Elyaman W; Xiao S; Regev A; Kuchroo VK
Cell Rep; 2016 Jul; 16(2):392-404. PubMed ID: 27346359
[TBL] [Abstract][Full Text] [Related]
19. Cutting edge: IL-21 is not essential for Th17 differentiation or experimental autoimmune encephalomyelitis.
Coquet JM; Chakravarti S; Smyth MJ; Godfrey DI
J Immunol; 2008 Jun; 180(11):7097-101. PubMed ID: 18490706
[TBL] [Abstract][Full Text] [Related]
20. CCR7 ligands are required for development of experimental autoimmune encephalomyelitis through generating IL-23-dependent Th17 cells.
Kuwabara T; Ishikawa F; Yasuda T; Aritomi K; Nakano H; Tanaka Y; Okada Y; Lipp M; Kakiuchi T
J Immunol; 2009 Aug; 183(4):2513-21. PubMed ID: 19625643
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
